AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$602M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$491M |
| 3 |
Booking.com
BKNG
|
+$290M |
| 4 |
Monster Beverage
MNST
|
+$238M |
| 5 |
US Foods
USFD
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$561M |
| 2 |
Tyson Foods
TSN
|
+$321M |
| 3 |
Intel
INTC
|
+$301M |
| 4 |
Honeywell
HON
|
+$247M |
| 5 |
Biogen
BIIB
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.25% |
| 2 | Financials | 16.11% |
| 3 | Healthcare | 14.54% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Silicon Motion
SIMO
$7.82B
| $462K | ﹤0.01% |
8,610
+3,570
| +71% | +$198K |
|
2652
TG Therapeutics
TGTX
$7.52B
| $462K | ﹤0.01% |
82,540
+19,900
| +32% | +$227K |
|
2653
Citizens
CIA
$194M
| $460K | ﹤0.01% |
54,809
| – | – |
|
2654
American Coastal Insurance
ACIC
$470M
| $459K | ﹤0.01% |
20,500
+800
| +4% | +$16.5K |
|
2655
BP
BP
$110B
| $459K | ﹤0.01% |
10,437
+5,625
| +117% | +$235K |
|
2656
Sonic Automotive
SAH
$2.53B
| $459K | ﹤0.01% |
23,745
| – | – |
|
|
GBL
2657
DELISTED
GAMCO Investors, Inc.
GBL
| $459K | ﹤0.01% |
19,585
+200
| +1% | +$5.16K |
|
2658
Akebia Therapeutics
AKBA
$234M
| $457K | ﹤0.01% |
51,800
| – | – |
|
|
CVLY
2659
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $456K | ﹤0.01% |
16,101
+8,730
| +118% | +$247K |
|
|
DRNA
2660
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $456K | ﹤0.01% |
29,900
+17,300
| +137% | +$252K |
|
2661
eHealth
EHTH
$40.4M
| $455K | ﹤0.01% |
16,100
+1,500
| +10% | +$39.8K |
|
|
GRP.U
2662
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $453K | ﹤0.01% |
10,564
-112
| -1% | -$4.71K |
|
|
MRLN
2663
DELISTED
Marlin Business Services Corp
MRLN
| $450K | ﹤0.01% |
15,600
| – | – |
|
2664
Aclaris Therapeutics
ACRS
$868M
| $449K | ﹤0.01% |
30,900
+2,100
| +7% | +$36K |
|
|
LJPC
2665
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $449K | ﹤0.01% |
22,300
-1,900
| -8% | -$49.7K |
|
2666
FS KKR Capital
FSK
$3.37B
| $448K | ﹤0.01% |
15,894
-68,754
| -81% | -$2.1M |
|
2667
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.41B
| $448K | ﹤0.01% |
35,399
| – | – |
|
|
ESND
2668
DELISTED
Essendant Inc.
ESND
| $445K | ﹤0.01% |
34,692
| – | – |
|
2669
CNB Financial Corp
CCNE
$1.02B
| $443K | ﹤0.01% |
15,340
| – | – |
|
2670
TFS Financial
TFSL
$4.83B
| $442K | ﹤0.01% |
29,416
-500
| -2% | -$7.81K |
|
2671
Arrow Financial
AROW
$644M
| $440K | ﹤0.01% |
13,777
-240
| -2% | -$7.79K |
|
|
SCWX
2672
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $440K | ﹤0.01% |
30,000
+1,100
| +4% | +$14.4K |
|
2673
JD.com
JD
$45.2B
| $439K | ﹤0.01% |
16,818
-26,719
| -61% | -$875K |
|
2674
Pilgrim's Pride
PPC
$6.31B
| $438K | ﹤0.01% |
24,188
-14,214
| -37% | -$263K |
|
|
ONDK
2675
DELISTED
On Deck Capital, Inc.
ONDK
| $438K | ﹤0.01% |
57,800
+5,100
| +10% | +$39.7K |
|
Similar funds
AllianceBernstein's Q3 2018 Portfolio in Review
As of Q3 2018, AllianceBernstein held 3,205 positions worth $153B, up 6.6% from $144B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
AllianceBernstein's Q3 2018 filing shows 99 new, 1,186 increased, 1,226 reduced and 67 closed positions. Its largest new stake was Novo Nordisk: 2,995,420 shares worth $70.6M. The largest sale was Meta Platforms (Facebook), an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2018 buy was Novo Nordisk: 2,995,420 shares worth $70.6M.
- AllianceBernstein added most to Microsoft in Q3 2018, an estimated $602M increase.
- AllianceBernstein's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $561M.
- AllianceBernstein fully exited Education Realty Trust Inc in Q3 2018, selling an estimated $103M.
- AllianceBernstein's ten largest holdings make up 17% of its $153B portfolio in Q3 2018.
- AllianceBernstein opened 99 new positions and closed 67 in Q3 2018.
- AllianceBernstein's portfolio value rose 6.6% quarter-over-quarter to $153B.
Based on AllianceBernstein's 13F filing for Q3 2018, filed 8 Nov 2018.